Filling the gap: interventional occlusion of incompletely ligated left atrial appendages

Size: px
Start display at page:

Download "Filling the gap: interventional occlusion of incompletely ligated left atrial appendages"

Transcription

1 Europace (2015) 17, doi: /europace/euu164 CLINICAL RESEARCH Ablation for atrial fibrillation Filling the gap: interventional occlusion of incompletely ligated left atrial appendages Stefano Bordignon, Alexander Fürnkranz, Laura Perrotta, Daniela Dugo, Athanasios Kostantinou, Britta Schullte-Hahn, Bernd Nowak, KR Julian Chun and Boris Schmidt* Med. Klinik III, Cardioangiologisches Centrum Bethanien, Markus Krankenhaus, Wilhelm-Epstein-Str. 4, Frankfurt am Main, Germany Received 22 March 2014; accepted after revision 26 May 2014; online publish-ahead-of-print 6 August 2014 Aims Patients undergoing heart surgery and with history of atrial fibrillation are often treated with intraoperative left atrial appendage (LAA) ligation. Incomplete LAA ligation is often described and can be associated with thrombo-embolic complications. To describe a case series of percutaneous LAA occlusion in patients previously treated with surgical LAA ligation.... Methods Over 179 patients treated with implantation of an LAA occluder system at our centre, 3 (1.6%) were previously treated and results with a surgical LAA suture exclusion (2 males, age years). Patients 1 and 3 presented a hammerhead LAA morphology with an open neck and were successfully treated with an AGA Cardiac Plug (ACP St Jude Medical) Device. Patient 2 had a conic monolobar LAA with a small neck, and the occlusion could be performed using a Watchman (Boston Scientific) device. After discharge on dual antiplatelet therapy, all the patients could be switched to single aspirin (ASA) therapy after a 6-week transoesophageal echocardiography control.... Conclusion Left atrial appendage occlusion in patient with incomplete surgical ligation using percutaneous LAA occluder devices appears to be feasible, and studies including a larger number of patients are needed Keywords Percutaneous LAA occlusion Surgically ligation Stroke prevention Atrial fibrillation Introduction In patients with a history of atrial fibrillation (AF) undergoing open heart surgery, left atrial appendage (LAA) ligation or exclusion may be considered. 1,2 Since many years, this technique has been performed by surgeons in patients undergoing mitral valve surgery, 3 and coronary artery bypass interventions. 4 While no evidence from randomized studies exists on stroke risk reduction by surgical LAA ligation, several follow-up studies demonstrated incomplete exclusion of the LAA after surgery in up to 60% of patients by transoesophageal echocardiography (TEE). 5 7 Thereby, LAA suture exclusion was the most unsuccessful technique compared with LAA excision or with stapler exclusion. Moreover, in 41% of all patients with incomplete LAA exclusion a LAA thrombus was found, suggesting that incomplete LAA exclusion may increase thrombogenicity. Oppositely, interventional LAA occlusion results in favourable clinical outcomes compared with medical therapy Therefore, it remains uncertain, whether patients with incompletely ligated LAAs should undergo an interventional LAA occlusion procedure. We therefore sought to determine the feasibility of interventional LAA closure with different devices. Methods All procedures were performed in conscious sedation using boluses of midazolam, fentanyl, followed by a 1% propofol infusion. First, a careful analysis of the individual LAA anatomy was performed and the absence of intracardiac thrombus was documented using TEE. Left atrial appendage anatomy was evaluated in several planes (08, 458, 908, 1358) to determine the LAA ostial geometry, the LAA neck size and length, and to define the number and size of LAA lobes. Left atrial appendage depth was measured comparing the largest longitudinal axis to the largest transversal axis. After single transseptal puncture in a modified Brockenbrough technique, a 8F transseptal sheath (SL-1, St Jude Medical) was advanced to the left atrium (LA). Immediately after transseptal puncture, a heparin * Corresponding author. Tel: ; fax: address: b.schmidt@ccb.de Published on behalf of the European Society of Cardiology. All rights reserved. & The Author For permissions please journals.permissions@oup.com.

2 Percutaneous occlusion of surgically ligated LAA 65 What s new? No clear data about management of incompletely ligated left atrial appendage (LAA) are available. A recent case series shows that incompletely ligated LAA can be managed with a percutaneous occlusion using a device designed for patent foramen ovale occlusion. We first report occlusion of incompletely surgically ligated LAA using percutaneous LAA occluder devices, describing anatomical characteristics that help in the choice of the device. bolus of 100 IU/kg body weight was administered to maintain the activated clotting time.250 s. Using a pigtail catheter, complementary LAA angiographies were carried out in two different angulations [right anterior oblique (RAO) 308,208 caudal and RAO 308/158 cranial]. After proper device selection, the transseptal sheath was exchanged for the delivery sheath using a guidewire in the left superior pulmonary vein. Procedural details on the implant process are given in the Results section. Results Over 179 patients treated with implantation of an LAA occluder system at our centre, 3 (1.6%) were previously treated with a surgical LAA suture exclusion. The following three procedural (anatomical) characteristics were found. Patient characteristics Patient #1, a 72-year-old male with persistent AF, underwent aortic valve replacement and mitral valve reconstruction in 2011 accompanied by LAA ligation and intraoperative cryoablation. During two additional catheter ablations, LA substrate modification was performed resulting in electrical LAA isolation. Patient #2, a 73-year-old male with paroxysmal AF, had a triple coronary artery bypass surgery with LAA ligation in Due to labile international normalized ratio (INR) values and a high bleeding risk, LAA occluder implantation was proposed. Patient #3, a 76-year-old female with paroxysmal AF, underwent mitral valve reconstruction for severe mitral regurgitation in conjunction with LAA ligation in After multiple ablation procedures resulting in electrical LAA isolation, LAA occlusion was performed due to a high bleeding risk. Ligated left atrial appendage with major transversal axis open neck with hammerhead left atrial appendage In Patients #1 and #3, TEE and LAA angiography revealed a hammerhead morphology determined by a narrow and very short neck and a major transversal axis with a short posterior and long anterior pseudo-lobe (Figures 1A and 3A/B). This distorted anatomy resulted in an absent landing zone as well as missing longitudinal depth required for the regular AGA Cardiac Plug (ACP) or Watchman implantations. We therefore decided to use the LAA isthmus at Figure 1 Left atrial appendage occlusion in Patient 1. See the text for description.

3 66 S. Bordignon et al. Figure 2 Left atrial appendage occlusion in Patient 3. See the text for description. the neck as anchoring zone for the waist between the lobe and the disc of an ACP device. In both cases, the LAA orifice was cannulated with the ball-shaped, partially opened lobe of the ACP device (24 and 20 mm in #1 and #3, respectively; Figures 1B and 3C). Then, the device was actively pushed beyond the LAA neck to allow for a complete ACP lobe release in both LAA pseudo-lobes (Figure 1C). Lobe stability was assessed by a light pull manoeuvre at the sheath. Subsequently, the ACP disc was released by unsheathing (Figures 1D and 3D) and coverage of the LAA ostium was assessed, both, by TEE and contrast injection (Figures 1E and 3E). Both procedures were performed uneventful. Ligated left atrial appendage with a major longitudinal axis conic monolobar mini neck In Patient #2, TEE indicated a very narrow LAA orifice of 5 mm opening into a single lobe, conic-shaped LAA (Figure 2A). This hindered LAA cannulation with a ball-shaped ACP device. For LAA angiography, the LAA was intubated with the transseptal sheath guided via a steerable diagnostic electrophysiology catheter (Biosense Webster, D-Type, 6F; Figure 2B). Due to its conic shape, we opted for a 21 mm Watchman LAA occlusion device. The transseptal sheath was exchanged for the delivery system via a wire (Amplatz Extra Stiff Wire Guide Cook Inc.) placed in the LAA (Figure 2C and D). Due to the short longitudinal LAA axis, the delivery sheath was positioned only few millimetres behind the LAA orifice, but the appropriate delivery marker could not be placed at the presumed landing zone. Therefore, the device release had to be performed by a combined active device pushing and de-sheathing, so called wave-ride manoeuvre assuring a static position of the device distal to the LAA orifice (Figure 2E and F). Complete occlusion was confirmed by TEE. Post-procedural follow-up After exclusion of pericardial effusion, all patients were discharged on dual antiplatelet therapy [aspirin (ASA) 100 mg and clopidogrel 75 mg per day]. After 6 weeks, a TEE confirmed persistent LAA occlusion without thrombus formation on the occluder in all patients. Consequently, clopidogrel therapy was stopped. During a follow-up of 7, 8, and 16 months, respectively, no thrombo-embolic or haemorrhagic complications occurred on ASA monotherapy. Discussion The present case series illustrates the pitfalls of interventional LAA occlusion in patients who had previously undergone incomplete surgical LAA ligation. It highlights the procedural manoeuvres as well as the importance of perfect imaging of the individual LAA anatomy to employ the appropriate implant strategy. Pitfalls of surgical left atrial appendage ligation In AF patients undergoing heart surgery, concomitant LAA ligation may be considered according to current AF guidelines (Level of

4 Percutaneous occlusion of surgically ligated LAA 67 Figure 3 Left atrial appendage occlusion in Patient 2. See the text for description. evidence C), 1 although randomized trials proving its efficacy in stroke prevention are missing. Among the different surgical techniques, LAA excision may provide the most reliable results, but stapling and ligation are the most commonly performed interventions. While in the LAAOS trial suture and stapler exclusion were proven to be safe, postprocedural TEEs revealed complete LAA occlusion in only 45 72% of patients with suture or stapler ligation, respectively. 4 In several studies, as a result of the persistent LA to LAA communication, thrombus formation was detected in 40% of patients. 7,12,13 The risk of embolization due to incomplete surgically ligated LAA is not well assessed. These patients could be treated with standard oral anticoagulation. The exact INR range in this setting is unknown, because incomplete ligation may predispose to thrombus formation in pockets of stagnant blood flow. This highlights the clinical relevance of interventional LAA closure in patients with incomplete LAA ligation as an alternative to continuing oral anticoagulation. Electrical left atrial appendage isolation as an indication to percutaneous left atrial appendage occlusion In two of the presented patients, the LAA was electrically isolated during repeated AF ablation procedures. These patients have a higher thrombo-embolic risk, due to impaired LAA transport function represented by decreased emptying velocities. 14 Percutaneous LAA occlusion seems to be a reasonable alternative to lifelong oral anticoagulants (OAC). Implantation success In recent reports, implant success rates vary between 90 and 95% using the Watchman device. 9,10 The success rate is determined by operator experience, but also by the suitability of the individual LAA anatomy to the available devices, as recently demonstrated in a case series using an Amplatzer septal occluder device. 15 In the present series, anatomical characteristics were described, favoring occluder selection and demonstrating that LAA occluder devices can be used in previously ligated LAA. Pre-procedural imaging using TEE is an indispensable pre-requisite for a successful implantation. Moreover, procedural tricks may have to be employed to successfully implant the LAA occluder. Due to the distorted anatomy, the delivery sheath could only be advanced to the presumed landing zone. Device release was accomplished by a push pull manoeuvre to ascertain a proper placement. However, actively pushing the device out of the sheath is not recommended to avoid cardiac perforation. Limitations We report our results about occlusion of LAA incompletely ligated in a small case series among a bigger collective of percutaneous LAA occlusion. The small number of patients reflects the relatively low incidence of this clinical condition. More data are needed to

5 68 S. Bordignon et al. define safety and efficacy of percutaneous occlusion of incompletely ligated LAA. Conclusion Given the high acute procedural success rate and the favourable mid-term outcome of the presented patients, interventional LAA closure in patients with incompletely ligated LAAs may offer a sound alternative to OAC continuation. Conflict of interest: B.S. is an advisory-board member for Boston Scientific and St Jude Medical. All other authors have no disclosure regarding this topic. Funding S.B. and L.P. were supported by an EHRA-Fellowship education grant. References 1. Camm AJ, Lip GYH, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the EuropeanHeart Rhythm Association. Europace 2012;14: Lewalter T, Kanagaratnam P, Schmidt B, Rosenqvist M, Nielsen-Kudsk JE, Ibrahim R et al. Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion. Europace 2014;16: Madden JL. Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli. J Am Med Assoc 1949;140: Healey JS, Crystal E, Lamy A, Teoh K, Semelhago L, Hohnloser SH et al. Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J 2005;150: Katz ES, Tsiamtsiouris T, Applebaum RM, Schwartzbard A, Tunick PA, Kronzon I. Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study. J Am Coll Cardiol 2000;36: Garcia-Fernandez MA, Perez-David E, Quiles J, Peralta J, Garcıa-Rojas I, Bermejo J et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J Am Coll Cardiol 2003;42: Kanderian AS, Gillinov AM, Pettersson GB, Blackstone E, Klein AL. Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. J Am Coll Cardiol 2008;52: Sievert H. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation 2002;105: Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry (CAP). Circulation 2011;123: Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial (Protect AF). Lancet 2009;374: Elsevier Ltd. 11. Chun KJ, Bordignon S, Urban V, Perrotta L, Dugo D, Fürnkranz A et al. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience. Heart Rhythm 2013;10: Donnino R, Tunick PA, Kronzon I. Left atrial appendage thrombus outside of a successful ligation. Eur J Echocardiogr 2008;9: Rosenzweig BP, Katz E, Kort S, Schloss M, Kronzon I. Thromboembolus from a ligated left atrial appendage. J Am Soc Echocardiogr 2001;14: Tilz RR, Schmidt B, Menon SD, Chun KR, Fuernkranz A, Metzner A et al. Abstract 2253: left atrial appendage function and clinical outcome after electrical isolation of left atrial appendage in patients undergoing atrial fibrillation ablation (Abstract). Circulation 2008;118:S_694 S_ Aryana A, Cavaco D, Arthur A, O Neill PG, Adragão P, D Avila A. Percutaneous endocardial occlusion of incompletely surgically ligated left atrial appendage. J Cardiovasc Electrophysiol 2013;24:

Abstract 1 INTRODUCTION ORIGINAL ARTICLE

Abstract 1 INTRODUCTION ORIGINAL ARTICLE Received: 5 October 2017 Revised: 2 November 2017 Accepted: 6 November 2017 DOI: 10.1111/jce.13385 ORIGINAL ARTICLE Feasibility of percutaneous left atrial appendage closure using a novel LAmbre occluder

More information

Atrial fibrillation (AF), one of the

Atrial fibrillation (AF), one of the Hellenic J Cardiol 2013; 54: 408-412 Case Report Left Atrial Appendage Occlusion with the Amplatzer Amulet for Stroke Prevention in Atrial Fibrillation: The First Case in Greece Apostolos Tzikas, Lambros

More information

Chapter 76 Left Atrial Appendage Closure: Indication and Technique

Chapter 76 Left Atrial Appendage Closure: Indication and Technique Chapter 76 Left Atrial Appendage Closure: Indication and Technique RANJAN SHETTY INTRODUCTION Atrial fibrillation (AF) is one of the most common cardiac arrhythmias, which affects around 3% 5% of the population

More information

Devices to Protect Against Stroke in Atrial Fibrillation

Devices to Protect Against Stroke in Atrial Fibrillation Devices to Protect Against Stroke in Atrial Fibrillation Jonathan C. Hsu, MD, MAS Associate Clinical Professor Division of Cardiology, Section of Cardiac Electrophysiology June 2, 2018 Disclosures Honoraria

More information

Left atrial appendage closure with the Amplatzer Cardiac Plug: Rationale for a higher degree of device oversizing at implantation

Left atrial appendage closure with the Amplatzer Cardiac Plug: Rationale for a higher degree of device oversizing at implantation ORIGINAL ARTICLE Cardiology Journal 2015, Vol. 22, No. 2, 201 205 DOI: 10.5603/CJ.a2014.0063 Copyright 2015 Via Medica ISSN 1897 5593 Left atrial appendage closure with the Amplatzer Cardiac Plug: Rationale

More information

Patients selection criteria for LAA occlusion. Young Keun On, MD, PhD, FHRS Samsung Medical Center Sungkyunkwan University School of Medicine

Patients selection criteria for LAA occlusion. Young Keun On, MD, PhD, FHRS Samsung Medical Center Sungkyunkwan University School of Medicine Patients selection criteria for LAA occlusion Young Keun On, MD, PhD, FHRS Samsung Medical Center Sungkyunkwan University School of Medicine Atrial Fibrillation The most common cardiac arrhythmia. Confers

More information

Case Report Hemostasis of Left Atrial Appendage Bleed With Lariat Device

Case Report Hemostasis of Left Atrial Appendage Bleed With Lariat Device 273 Case Report Hemostasis of Left Atrial Appendage Bleed With Lariat Device Amena Hussain MD, Muhamed Saric MD, Scott Bernstein MD, Douglas Holmes MD, Larry Chinitz MD NYU Langone Medical Center, United

More information

Left atrial appendage closure indications, techniques, and outcomes: results of the European Heart Rhythm Association Survey

Left atrial appendage closure indications, techniques, and outcomes: results of the European Heart Rhythm Association Survey Europace (2015) 17, 642 646 doi:10.1093/europace/euv069 EP WIRE Left atrial appendage closure indications, techniques, and outcomes: results of the European Heart Rhythm Association Survey Laurent Pison

More information

Introduction EP WIRE. ... Keywords

Introduction EP WIRE. ... Keywords Europace (217), 1 6 doi:1.3/europace/eux254 EP WIRE Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association

More information

Thessaloniki October 9, Apostolos Tzikas MD, PhD, FESC

Thessaloniki October 9, Apostolos Tzikas MD, PhD, FESC 7 th IICE Congress Thessaloniki October 9, 2014 Left atrial appendage occlusion with the Amplatzer Amulet: a case report Apostolos Tzikas MD, PhD, FESC Interventional Cardiologist Structural & Congenital

More information

Endocardial LAA Occlusion: Which Device for Which Patient?

Endocardial LAA Occlusion: Which Device for Which Patient? Endocardial LAA Occlusion: Which Device for Which Patient? Roy Beinart, MD Davidai Arrhythmia Center The Leviev Heart Center Sheba Medical Center Sheba Medical Center Tel Hashomer The Leviev Heart Center

More information

Occlusion de l'auricule gauche: Niche ou réel avenir? D Gras, MD, Nantes, France

Occlusion de l'auricule gauche: Niche ou réel avenir? D Gras, MD, Nantes, France Occlusion de l'auricule gauche: Niche ou réel avenir? D Gras, MD, Nantes, France LAA Occlusion Is there a real future? Background Protect AF Trial Other Studies CAP, ASAP, Prevail Left Atrial Appendage

More information

Left Atrial Appendage Occlusion: Shutting Out Embolic Disease Without Anticoagulation

Left Atrial Appendage Occlusion: Shutting Out Embolic Disease Without Anticoagulation Left Atrial Appendage Occlusion: Shutting Out Embolic Disease Without Anticoagulation Zoltan G. Turi, M.D. Rutgers Robert Wood Johnson Medical School New Brunswick, NJ Disclosure Information Zoltan G.

More information

Role of cardiac imaging for catheterbased left atrial appendage closure

Role of cardiac imaging for catheterbased left atrial appendage closure Role of cardiac imaging for catheterbased left atrial appendage closure Ana G. Almeida, MD, PhD Cardiology University Hospital Santa Maria, Lisbon Ana G. Almeida, MD, PhD, FESC University Hospital Santa

More information

Continuing Cardiology Education

Continuing Cardiology Education Continuing Cardiology Education REVIEW ARTICLE Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: indications diversity and future perspectives A. Tzikas 1 & T.

More information

Percutaneous Epicardial LAA Closure: When Does it Make Sense?

Percutaneous Epicardial LAA Closure: When Does it Make Sense? Percutaneous Epicardial LAA Closure: When Does it Make Sense? Petr Neuzil, MD,PhD, FESC Professor of Medicine Cardiology department Na Homolce Hospital, Prague, Czechia petr.neuzil@gmail.com Disclosures

More information

LAA Occluders: The Right Device for the Right Patient ACC/SHA MEETING OCTOBER 31 ST 2015 JEDDAH, KSA OMER A. M. ELAMIN, MD, FACC

LAA Occluders: The Right Device for the Right Patient ACC/SHA MEETING OCTOBER 31 ST 2015 JEDDAH, KSA OMER A. M. ELAMIN, MD, FACC LAA Occluders: The Right Device for the Right Patient ACC/SHA MEETING OCTOBER 31 ST 2015 JEDDAH, KSA OMER A. M. ELAMIN, MD, FACC INTERVENTIONAL CARDIOLOGIST DIRECTOR, ADULT CARDIOLOGY FELLOWSHIP TRAINING

More information

Left atrial appendage occlusion

Left atrial appendage occlusion Kardiologie Left atrial appendage occlusion Mischa Kühne Kardiolunch, 10.9.2015 Overall stroke rate 5% per year CHA 2 DS 2 VASC score Most AF patients need protection from stroke ESC guidelines AF, 2010/2012

More information

Incomplete surgical ligation of the left atrial appendage time for a new look at an old problem

Incomplete surgical ligation of the left atrial appendage time for a new look at an old problem Editorial Page 1 of 5 Incomplete surgical ligation of the left atrial appendage time for a new look at an old problem Arash Aryana, Rohit Bhaskar Mercy General Hospital and Dignity Health Heart and Vascular

More information

Left Atrial Appendage Closure Devices. Atrial Fibrillation 10/11/2017

Left Atrial Appendage Closure Devices. Atrial Fibrillation 10/11/2017 Left Atrial Appendage Closure Devices Emile Daoud, MD Chief, Cardiac Electrophysiology Wexner Medical Center, The Ohio State University Atrial Fibrillation 1 Adjusted Annual Stroke Risk Using CHA 2 DS

More information

Left Atrial Appendage Closure: Moving Beyond Blood Thinners to Prevent Stroke in Atrial Fibrillation October 29, 2016

Left Atrial Appendage Closure: Moving Beyond Blood Thinners to Prevent Stroke in Atrial Fibrillation October 29, 2016 Left Atrial Appendage Closure: Moving Beyond Blood Thinners to Prevent Stroke in Atrial Fibrillation October 29, 2016 Jesse Jorgensen, MD, FACC Director, Cardiac Cath Lab, Greenville Health System Disclosures

More information

Modern aspects in multidisciplinary thromboembolic prophylaxis. AMPLATZER Left Atrial Appendage data update

Modern aspects in multidisciplinary thromboembolic prophylaxis. AMPLATZER Left Atrial Appendage data update Modern aspects in multidisciplinary thromboembolic prophylaxis AMPLATZER Left Atrial Appendage data update Igal Moarof, MD Interventional Cardiology Kantonsspital Aarau Potential conflicts of interest

More information

THINK OUTSIDE THE PILLBOX

THINK OUTSIDE THE PILLBOX WATCHMAN : A CLINICALLY PROVEN AND SAFE THERAPY FOR YOUR NVAF PATIENTS WATCHMAN reduces the risk of stroke in NVAF patients as effectively as warfarin WATCHMAN also reduces the long-term risk of bleeding

More information

Catheter-based left atrial appendage occlusion procedure: role of echocardiography

Catheter-based left atrial appendage occlusion procedure: role of echocardiography European Heart Journal Cardiovascular Imaging (2012) 13, 132 138 doi:10.1093/ejechocard/jer158 REVIEWS Catheter-based left atrial appendage occlusion procedure: role of echocardiography Gila Perk 1 *,

More information

Left atrial catheter ablation subsequent to Watchman w left atrial appendage device implantation: a single centre experience

Left atrial catheter ablation subsequent to Watchman w left atrial appendage device implantation: a single centre experience Europace (2015) 17, 1402 1406 doi:10.1093/europace/euv037 CLINICAL RESEARCH Ablation for atrial fibrillation Left atrial catheter ablation subsequent to Watchman w left atrial appendage device implantation:

More information

Atrial fibrillation (AF) affects approximately 33 million

Atrial fibrillation (AF) affects approximately 33 million Emerging Options for Anticoagulation in LAA Closure Managing anticoagulation and antiplatelet therapy in patients undergoing percutaneous left atrial appendage closure with the Watchman device. BY JESSICA

More information

Is there a role for transcatheter left atrial appendage occlusion?

Is there a role for transcatheter left atrial appendage occlusion? REVIEW Review Is there a role for transcatheter left atrial appendage occlusion? For patients with atrial fibrillation, successful warfarin therapy is difficult in clinical practice. Thus, it seems logical

More information

Atrial fibrillation (AF) is a common arrhythmia worldwide

Atrial fibrillation (AF) is a common arrhythmia worldwide Left Atrial Appendage Closure Under Intracardiac Echocardiographic Guidance: Feasibility and Comparison With Transesophageal Echocardiography Yae Matsuo, MD;* Petr Neuzil, MD, PhD;* Jan Petru, MD; Milan

More information

THINK OUTSIDE THE PILLBOX

THINK OUTSIDE THE PILLBOX THINK OUTSIDE THE PILLBOX An innovative one-time procedure that reduces the risk of stroke in your non-valvular atrial fibrillation (NVAF) patients and the long-term risk of bleeding that comes with a

More information

ATRIAL SEPTAL CLOSURE AND LEFT ATRIAL APPENDAGE OCCLUSION: INDICATIONS AND GUIDANCE ECHOCARDIOGRAPHY IN INTERVENTIONAL CARDIOLOGY

ATRIAL SEPTAL CLOSURE AND LEFT ATRIAL APPENDAGE OCCLUSION: INDICATIONS AND GUIDANCE ECHOCARDIOGRAPHY IN INTERVENTIONAL CARDIOLOGY ATRIAL SEPTAL CLOSURE AND LEFT ATRIAL APPENDAGE OCCLUSION: INDICATIONS AND GUIDANCE Aristides G. Panlilio, MD, FPCP, FPCC,FPSE, FASE Philippine Heart Center Chinese General Hospital and Medical Center

More information

Watchman. Left Atrial Appendage Closure Device. Uniquely engineered for the LAA 1-3 with proven safety and longterm efficacy. 4-8

Watchman. Left Atrial Appendage Closure Device. Uniquely engineered for the LAA 1-3 with proven safety and longterm efficacy. 4-8 TM Watchman Left Atrial Appendage Closure Device PROOF OFLEADERSHIP Uniquely engineered for the LAA 1-3 with proven safety and longterm efficacy. 4-8 Patients with AF have a 5x increased risk of stroke.

More information

The evolving role of left atrial appendage occlusion

The evolving role of left atrial appendage occlusion ORIGINAL ARTICLE 288 A high-volume single-centre experience The evolving role of left atrial appendage occlusion Raffael A. Ghenzi, Slayman Obeid, Francesco Maisano, Maurizio Taramasso, Ronald Binder,

More information

Medical Policy Manual. Topic: Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation. Date of Origin: December 2011

Medical Policy Manual. Topic: Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation. Date of Origin: December 2011 Medical Policy Manual Topic: Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation Date of Origin: December 2011 Section: Medicine Last Reviewed Date: October 2013 Policy No:

More information

Case Report Pulmonary Vein Compression After Implantation of a Left Atrial Appendage Occluder: Presentation and Discussion of a Case

Case Report Pulmonary Vein Compression After Implantation of a Left Atrial Appendage Occluder: Presentation and Discussion of a Case 194 Case Report Pulmonary Vein Compression After Implantation of a Left Atrial Appendage Occluder: Presentation and Discussion of a Case Maryam Ayati MD, Feifan Ouyang MD, KH Kuck MD Department of cardiology,

More information

Appendage Closure. Jason Rogers, MD. Director, Interventional Cardiology UC Davis Medical Center Sacramento, California

Appendage Closure. Jason Rogers, MD. Director, Interventional Cardiology UC Davis Medical Center Sacramento, California Appendage Closure Jason Rogers, MD Director, Interventional Cardiology UC Davis Medical Center Sacramento, California Left Atrium: Atrial Fibrillation Left Atrial Appendage Left Atrium Incidence of Atrial

More information

THINK OUTSIDE THE PILLBOX

THINK OUTSIDE THE PILLBOX THINK OUTSIDE THE PILLBOX An innovative one-time procedure that reduces the risk of stroke in your non-valvular atrial fibrillation (NVAF) patients and the long-term risk of bleeding that comes with a

More information

Device-associated thrombus after percutaneous left atrial appendage closure: a case report and literature review

Device-associated thrombus after percutaneous left atrial appendage closure: a case report and literature review CSE REPORT Iwona Świątkiewicz, Marek Woźnicki, dam Sukiennik, Jacek Kubica Department of Cardiology and Internal Medicine, Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, ydgoszcz, Poland

More information

Technique, Risk, and Benefit. T. Santoso University of Indonesia Medical School,

Technique, Risk, and Benefit. T. Santoso University of Indonesia Medical School, Left Atrial Appendage Closure Technique, Risk, and Benefit T. Santoso University of Indonesia Medical School, Medistra Hospital, Jakarta, Indonesia Percutaneous LAA Closure Devices PLAATO (no longerdeveloped)

More information

Page 1. Current Trends in the Management of Atrial Fibrillation: Left Atrial Appendage Occlusion. Atrial fibrillation: Scope of the problem

Page 1. Current Trends in the Management of Atrial Fibrillation: Left Atrial Appendage Occlusion. Atrial fibrillation: Scope of the problem Current Trends in the Management of Atrial Fibrillation: Left Atrial Appendage Occlusion Benjamin A. D Souza, MD, FACC, FHRS Assistant Professor of Clinical Medicine Penn Presbyterian Medical Center Cardiac

More information

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acute ischemic stroke TOAST classification of, 270 Acute myocardial infarction (AMI) cardioembolic stroke following, 207 208 noncardioembolic

More information

Transseptal catheterization is frequently performed to

Transseptal catheterization is frequently performed to The Incidence and Long-Term Clinical Outcome of Iatrogenic Atrial Septal Defects Secondary to Transseptal Catheterization With a 12F Transseptal Sheath Sheldon M. Singh, MD; Pamela S. Douglas, MD, MACC,

More information

The CHADS Score Role in Managing Anticoagulation After Surgical Ablation for Atrial Fibrillation

The CHADS Score Role in Managing Anticoagulation After Surgical Ablation for Atrial Fibrillation The CHADS Score Role in Managing Anticoagulation After Surgical Ablation for Atrial Fibrillation Niv Ad, MD, Linda Henry, PhD, RN, Karen Schlauch, PhD, Sari D. Holmes, PhD, and Sharon Hunt, MBA Inova Heart

More information

Left atrium appendage closure: A new technique for patients at high hemorrhagic risk

Left atrium appendage closure: A new technique for patients at high hemorrhagic risk Left atrium appendage closure: A new technique for patients at high hemorrhagic risk Victoria Martin Yuste MD PhD ITC. Cardiology Department. Hospital Clinic. Barcelona SITE. Barcelona, Juin-9-2013 NON

More information

TITLE: Left Atrial Appendage Occlusion: Economic Impact and Existing HTA Recommendations

TITLE: Left Atrial Appendage Occlusion: Economic Impact and Existing HTA Recommendations TITLE: Left Atrial Appendage Occlusion: Economic Impact and Existing HTA Recommendations DATE: 29 September 2010 CONTEXT AND POLICY ISSUES: Atrial fibrillation (AF) is the irregular, rapid beating of the

More information

A PATIENT S GUIDE TO THE LEFT ATRIAL APPENDAGE CLOSURE. Reducing the risk of stroke in atrial fibrillation

A PATIENT S GUIDE TO THE LEFT ATRIAL APPENDAGE CLOSURE. Reducing the risk of stroke in atrial fibrillation A PATIENT S GUIDE TO THE LEFT ATRIAL APPENDAGE CLOSURE Reducing the risk of stroke in atrial fibrillation TABLE OF CONTENTS IMPORTANT Please Note: Information provided by Boston Scientific Corporation

More information

Role of Imaging in Complex LAA Closure Anatomies

Role of Imaging in Complex LAA Closure Anatomies Role of Imaging in Complex LAA Closure Anatomies Sameer Gafoor 1,2 1 Swedish Heart and Vascular: Ming Zhang, Paul Huang, Darryl Wells, Adam Zivin, John Petersen II, Madalena Petrescu, Nimish Muni, Eric

More information

Commercial Products Percutaneous left atrial appendage closure is considered medically necessary when the criteria above is met.

Commercial Products Percutaneous left atrial appendage closure is considered medically necessary when the criteria above is met. Medical Coverage Policy Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation EFFECTIVE DATE: 07 01 2016 POLICY LAST UPDATED: 09 04 2018 OVERVIEW Stroke prevention

More information

Left Atrial Appendage Closure: Techniques and Guidelines. Mohammad Shenasa, MD Heart & Rhythm Medical Group San Jose, CA

Left Atrial Appendage Closure: Techniques and Guidelines. Mohammad Shenasa, MD Heart & Rhythm Medical Group San Jose, CA Left Atrial Appendage Closure: Techniques and Guidelines Mohammad Shenasa, MD Heart & Rhythm Medical Group San Jose, CA May is Stroke Awareness Month 2 September is AF Awareness Month Lecture Highlights

More information

Left atrial appendage closure for thromboembolism prevention in patients with atrial fibrillation: advances and perspectives

Left atrial appendage closure for thromboembolism prevention in patients with atrial fibrillation: advances and perspectives Review Article Left atrial appendage closure for thromboembolism prevention in patients with atrial fibrillation: advances and perspectives Bin Kong 1,2, Yu Liu 1,2, He Huang 1,2, Hong Jiang 1,2, Congxin

More information

The Clinical Impact of Incomplete Left Atrial Appendage Closure With the Watchman Device in Patients With Atrial Fibrillation

The Clinical Impact of Incomplete Left Atrial Appendage Closure With the Watchman Device in Patients With Atrial Fibrillation Journal of the American College of Cardiology Vol. 59, No. 10, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.11.028

More information

Watchman a Stroke Prevention Technology for Patients with Atrial Fibrillation

Watchman a Stroke Prevention Technology for Patients with Atrial Fibrillation Watchman a Stroke Prevention Technology for Patients with Atrial Fibrillation Scripps hospital,la Jolla, CA Atrial fibrillation is a major source of cardiogenic embolic related stroke 500,000 strokes per

More information

NCVH Birmingham 2013 August 24, Michael S. Bailey, MD Birmingham Heart Clinic

NCVH Birmingham 2013 August 24, Michael S. Bailey, MD Birmingham Heart Clinic NCVH Birmingham 2013 August 24, 2013 Michael S. Bailey, MD Birmingham Heart Clinic NCVH Birmingham 2015 August 29, 2015 Michael S. Bailey, MD Birmingham Heart Clinic Left Atrial Anatomy Part of a larger

More information

Left atrial appendage closure: outcomes and challenges

Left atrial appendage closure: outcomes and challenges Neth Heart J (2017) 25:143 151 DOI 10.1007/s12471-016-0929-0 REVIEW ARTICLE Left atrial appendage closure: outcomes and challenges H. S. Suradi 1,2,3 Z.M.Hijazi 4 Published online: 9 December 2016 The

More information

Left Atrial Appendage Occlusion

Left Atrial Appendage Occlusion Left Atrial Appendage Occlusion A new strategy to prevent stroke in atrial fibrillation Ashok Talreja MD and Arijit Chanda MD VHVI symposium 24th February 2018 Outline of presentation 1. Risk of stroke

More information

Review Article Thromboembolism Prevention via Transcatheter Left Atrial Appendage Closure with Transeosophageal Echocardiography Guidance

Review Article Thromboembolism Prevention via Transcatheter Left Atrial Appendage Closure with Transeosophageal Echocardiography Guidance Hindawi Publishing Corporation rombosis Volume 2014, Article ID 832752, 6 pages http://dx.doi.org/10.1155/2014/832752 Review Article Thromboembolism Prevention via Transcatheter Left Atrial Appendage Closure

More information

Department of Neurology, Medical University of Silesia, Hospital No. 7, Professor Leszek Giec Upper Silesian Medical Centre, Katowice, Poland

Department of Neurology, Medical University of Silesia, Hospital No. 7, Professor Leszek Giec Upper Silesian Medical Centre, Katowice, Poland Original paper Percutaneous closure of the left atrial appendage for secondary prevention of stroke in patients with atrial fibrillation and contraindications to chronic anticoagulant therapy Anetta Lasek-Bal

More information

Atrial Fibrillaiton and Heart Failure: Anticoagulation therapy in all cases?

Atrial Fibrillaiton and Heart Failure: Anticoagulation therapy in all cases? Atrial Fibrillaiton and Heart Failure: Anticoagulation therapy in all cases? Nicolas Lellouche Fédération de Cardiologie Hôpital Henri Mondor Créteil Disclosure Statement of Financial Interest I currently

More information

Update in Left Atrial Appendage Occlusion: More Options

Update in Left Atrial Appendage Occlusion: More Options Update in Left Atrial Appendage Occlusion: More Options Sajjad A Sabir, MD Director, Structural Heart Disease Program Director, Interventional Echocardiography Director, Heart Valve Clinic Non-Valvular

More information

Different transseptal puncture for different procedures: Optimization of left atrial catheterization guided by transesophageal echocardiography

Different transseptal puncture for different procedures: Optimization of left atrial catheterization guided by transesophageal echocardiography Original Article Different transseptal puncture for different procedures: Optimization of left atrial catheterization guided by transesophageal echocardiography Andrea Radinovic 1, Patrizio Mazzone 1,

More information

Exclusion de l auricule gauche par voie percutanée

Exclusion de l auricule gauche par voie percutanée Exclusion de l auricule gauche par voie percutanée Jean-Michel Juliard, Dominique Himbert, Pierre Aubry, Eric Brochet, Alec Vahanian Hôpital Bichat, Paris Pas de conflit d intérêt 2012 The Left Atrial

More information

Left atrial appendage (LAA) closure is now a commercially

Left atrial appendage (LAA) closure is now a commercially Assessing Anatomy for Left Atrial Appendage Closure The roles of TEE and CTA in anatomic assessment and device selection for LAA closure. BY DEE DEE WANG, MD, AND MARVIN H. ENG, MD Left atrial appendage

More information

ICE 2012 Ioannina,

ICE 2012 Ioannina, ICE 2012 Ioannina, 15-12-2012 Case presentation Left Atrial Appendage Occlusion therapy for Stroke Prevention in Atrial Fibrillation Apostolos Tzikas MD, PhD, FESC Interventional Cardiology Congenital

More information

Atrial fibrillation (AF) remains the most common

Atrial fibrillation (AF) remains the most common The Spectrum of Devices for Percutaneous Left Atrial Appendage Occlusion A look at current and emerging nonpharmacologic stroke prevention therapies. BY LLUIS ASMARATS, MD, AND JOSEP RODÉS-CABAU, MD Atrial

More information

MEDICAL POLICY SUBJECT: PERCUTANEOUS LEFT ATRIAL APPENDAGE CLOSURE DEVICES EFFECTIVE DATE: 08/20/15 REVISED DATE: 10/20/16, 11/16/17

MEDICAL POLICY SUBJECT: PERCUTANEOUS LEFT ATRIAL APPENDAGE CLOSURE DEVICES EFFECTIVE DATE: 08/20/15 REVISED DATE: 10/20/16, 11/16/17 MEDICAL POLICY SUBJECT: PERCUTANEOUS LEFT ATRIAL CATEGORY: Technology assessment PAGE: 1 OF: 8 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply.

More information

LAA and Stroke Prevention

LAA and Stroke Prevention LAA and Stroke Prevention Samuel J. Asirvatham, MD Professor of Medicine, Professor of Pediatrics Program Director Cardiac Electrophysiology; Vice Chair Innovations Mayo Clinic Turin, October 26, 2012

More information

Concomitant procedures using minimally access

Concomitant procedures using minimally access Surgical Technique on Cardiac Surgery Concomitant procedures using minimally access Nelson Santos Paulo Cardiothoracic Surgery, Centro Hospitalar de Vila Nova de Gaia, Oporto, Portugal Correspondence to:

More information

Watchman and Structural update..the next frontier. Ari Chanda, MD Cardiology Associates of Fredericksburg

Watchman and Structural update..the next frontier. Ari Chanda, MD Cardiology Associates of Fredericksburg Watchman and Structural update..the next frontier Ari Chanda, MD Cardiology Associates of Fredericksburg Different Left Atrial Appendage (LAA) morphologies Watchman (the device) Fabric Anchors Device structure

More information

Atrial fibrillation (AF) is the most common

Atrial fibrillation (AF) is the most common Left Atrial Appendage Closure With the Watchman Device A review of trial results and clinical application. BY JAYANT KHITHA, MD, AND TANVIR K. BAJWA, MD Atrial fibrillation (AF) is the most common arrhythmia

More information

Left Atrial Appendage Closure for Atrial Fibrillation 2015 UPDATE

Left Atrial Appendage Closure for Atrial Fibrillation 2015 UPDATE Left Atrial Appendage Closure for Atrial Fibrillation 2015 UPDATE Adam Greenbaum, MD NCVH Detroit 2015-09-12 Disclosures Former proctor: SentreHEART Discussion may include the use of non-fda approved devices

More information

Manuel Castellá Cardiovascular Surgery Hospital Clínic, Universidad de

Manuel Castellá Cardiovascular Surgery Hospital Clínic, Universidad de When not to exclude the LAA Manuel Castellá Cardiovascular Surgery Hospital Clínic, Universidad de Barcelona mcaste@clinic.ub.es @mcastellamd Normal hearts Patient in sinus rhythm Patient in AF (with

More information

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term Prevention of Stroke Saibal Kar, MD

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term Prevention of Stroke Saibal Kar, MD Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term Prevention of Stroke Saibal Kar, MD Director of Interventional Cardiac Research Cedars Sinai Medical Center Disclosure Statement

More information

Original Article. Introduction. Resumo

Original Article. Introduction. Resumo Percutaneous : Feasibility, Safety and Effect on Echocardiographic Parameters of Cardiac Function and Anatomy Silvio H. Barberato, Costantino R. F. Costantini, Sergio G. Tarbine, Marcos Denk, Costantino

More information

Atrial Septal Defect Closure. Stephen Brecker Director, Cardiac Catheterisation Labs

Atrial Septal Defect Closure. Stephen Brecker Director, Cardiac Catheterisation Labs Stephen Brecker Director, Cardiac Catheterisation Labs ADVANCED ANGIOPLASTY Incorporating The Left Main 5 Plus Course Conflicts of Interest The following companies have supported educational courses held

More information

More than 6 million people worldwide suffer from atrial

More than 6 million people worldwide suffer from atrial Catheter-Based Left Atrial Appendage (LAA) Ligation for the Prevention of Embolic Events Arising From the LAA Initial Experience in a Canine Model Randall J. Lee, MD, PhD; Krzysztof Bartus, MD; Steven

More information

Left Atrial Appendage Closure Techniques: 2015

Left Atrial Appendage Closure Techniques: 2015 Left Atrial Appendage Closure Techniques: 2015 Ramon Quesada, MD, FACP, FACC, FSCAI Medical Director, Interventional Cardiology & Cardiac Research Medical Director, Structural Heart and TAVR Program Baptist

More information

Europe. Other LAA occlusion devices are in clinical development.

Europe. Other LAA occlusion devices are in clinical development. EXPERT REVIEW INTERVENTIONS FOR STRUCTURAL HEART DISEASE Left atrial appendage closure for stroke prevention in nonvalvular atrial fibrillation: rationale, devices in clinical development and insights

More information

Fabien Praz, Andreas Wahl, Sophie Beney, Stephan Windecker, Heinrich P. Mattle*, Bernhard Meier

Fabien Praz, Andreas Wahl, Sophie Beney, Stephan Windecker, Heinrich P. Mattle*, Bernhard Meier Procedural Outcome after Percutaneous Closure of Patent Foramen Ovale using the Amplatzer PFO Occluder Without Intra-Procedural Echocardiography in 1,000 Patients Fabien Praz, Andreas Wahl, Sophie Beney,

More information

MEDICAL POLICY MEDICAL POLICY DETAILS POLICY STATEMENT POLICY GUIDELINES DESCRIPTION. Page: 1 of 9

MEDICAL POLICY MEDICAL POLICY DETAILS POLICY STATEMENT POLICY GUIDELINES DESCRIPTION. Page: 1 of 9 Page: 1 of 9 MEDICAL POLICY MEDICAL POLICY DETAILS Medical Policy Title PERCUTANEOUS LEFT ATRIAL APPENDAGE CLOSURE DEVICES Policy Number 7.01.92 Category Technology assessment Effective Date 08/20/15 Revised

More information

Which System Is better?: Watchman or Cardiac Plug or Something Else?

Which System Is better?: Watchman or Cardiac Plug or Something Else? ANGIOPLASTY SUMMIT-TCTAP 2012 Seoul, Korea, April 24-27, 2012 Which System Is better?: Watchman or Cardiac Plug or Something Else? Horst Sievert, Annkathrin Brauth, Isabel Schulmeyer, Patrick Boehm, Jonas

More information

Rahul Jhaveri, M.D. The Heart Group of Lancaster General Health

Rahul Jhaveri, M.D. The Heart Group of Lancaster General Health Rahul Jhaveri, M.D. The Heart Group of Lancaster General Health INTRODUCTION Three recently published randomized controlled trials in The New England Journal of Medicine provide new information about closure

More information

[N] = No product variation, policy applies as stated [Y] = Standard product coverage varies from application of this policy, see below

[N] = No product variation, policy applies as stated [Y] = Standard product coverage varies from application of this policy, see below Original Issue Date (Created): July 26, 2011 Most Recent Review Date (Revised): November 26, 2013 Effective Date: February 1, 2014 I. POLICY The use of percutaneous left-atrial appendage closure devices

More information

Percutaneous Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation

Percutaneous Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation Percutaneous Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation Policy Number: 2.02.26 Last Review: 6/2014 Origination: 1/2012 Next Review: 12/2014 Policy Blue Cross and

More information

Transcatheter closure of patent foramen ovale using the internal jugular venous approach

Transcatheter closure of patent foramen ovale using the internal jugular venous approach New methods in diagnosis and therapy Transcatheter closure of patent foramen ovale using the internal jugular venous approach Przemysław Węglarz 1,2, Ewa Konarska-Kuszewska 2, Tadeusz Zębik 2, Piotr Kuszewski

More information

National Institute for Health and Clinical Excellence

National Institute for Health and Clinical Excellence National Institute for Health and Clinical Excellence 310/2 Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism Consultation table

More information

SURGICAL VS ELECTROPHYSIOLOGICAL INTERVENTIONS FOR CARDIAC ARRHYTHMIAS DEBATE 2: LAA CLOSURE IS BEST DONE WITH DEVICES

SURGICAL VS ELECTROPHYSIOLOGICAL INTERVENTIONS FOR CARDIAC ARRHYTHMIAS DEBATE 2: LAA CLOSURE IS BEST DONE WITH DEVICES SURGICAL VS ELECTROPHYSIOLOGICAL INTERVENTIONS FOR CARDIAC ARRHYTHMIAS DEBATE 2: LAA CLOSURE IS BEST DONE WITH DEVICES Dr. Marco Barbierato Interventional Cardiology Cardio-Thoraco-Vascular Department

More information

Thoracoscopic Stand-Alone Left Atrial Appendectomy for Thromboembolism Prevention in Nonvalvular Atrial Fibrillation

Thoracoscopic Stand-Alone Left Atrial Appendectomy for Thromboembolism Prevention in Nonvalvular Atrial Fibrillation Journal of the American College of Cardiology Vol. 62, No. 2, 2013 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2013.01.017

More information

Non-Pharmacologic Stroke Prevention For Atrial fibrillation: A Practical Review for the Practicing Cardiologist

Non-Pharmacologic Stroke Prevention For Atrial fibrillation: A Practical Review for the Practicing Cardiologist Review articles A Journal of Cardiological Society of India, Kerala Chapter Non-Pharmacologic Stroke Prevention For Atrial fibrillation: A Practical Review for the Practicing Cardiologist a b c Srinivasa

More information

Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation Section Medicine

Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation Section Medicine 2.02.26 Percutaneous Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation Section Medicine Effective Date August 29, 2014 Subsection Cardiology Original Policy Date July 6,

More information

Percutaneous atrial septal defect closure with the Occlutech Figulla Flex ASD Occluder.

Percutaneous atrial septal defect closure with the Occlutech Figulla Flex ASD Occluder. Percutaneous atrial septal defect closure with the Occlutech Figulla Flex ASD Occluder. First case with a novel delivery system. Werner Budts, Md, PhD, FESC Congenital and Structural Cardiology University

More information

Structural Heart Disease: Setting the Stage for Success

Structural Heart Disease: Setting the Stage for Success Structural Heart Disease: Setting the Stage for Success Brenda McCulloch, RN MSN RCIS Cardiovascular Clinical Nurse Specialist, Interventional & Medical Cardiology Sutter Medical Center, Sacramento mccullb@sutterhealth.org

More information

Clinical Data Summary & Discussion Of the Ultraseal Left Atrial Appendage (LAA) Closure Device

Clinical Data Summary & Discussion Of the Ultraseal Left Atrial Appendage (LAA) Closure Device Clinical Data Summary & Discussion Of the Ultraseal Left Atrial Appendage (LAA) Closure Device The clinical data used to support the CE marking of the Ultraseal LAA Closure device comes from three sources.

More information

2018 CODING AND REIMBURSEMENT FOR. Cardiac Surgical Ablation and Left Atrial Appendage Management

2018 CODING AND REIMBURSEMENT FOR. Cardiac Surgical Ablation and Left Atrial Appendage Management 2018 CODING AND REIMBURSEMENT FOR Cardiac Surgical Ablation and Left Atrial Appendage Management Introduction This information is shared for educational purposes and current as of January 2018. Healthcare

More information

Update in the Management of Atrial Fibrillation

Update in the Management of Atrial Fibrillation Update in the Management of Atrial Fibrillation Gregory M Marcus, MD, MAS Associate Professor of Medicine Division of Cardiology University of California, San Francisco Disclosures Research: Gilead, Medtronic,

More information

The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It. Chandra Kumbar MD FACC FHRS The Heart Group, Evansville IN

The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It. Chandra Kumbar MD FACC FHRS The Heart Group, Evansville IN The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It Chandra Kumbar MD FACC FHRS The Heart Group, Evansville IN Disclosures Consultant Advisory Board, Medtronic Atrial fibrillation

More information

Left Atrial Appendage Closure: The Rationale

Left Atrial Appendage Closure: The Rationale Left Atrial Appendage Closure: The Rationale JOHN D. HUMMEL, MD DIRECTOR OF CLINCAL ELECTROPHYSIOLOGY RESEARCH PROFESSOR OF CLINICAL INTERNAL MEDICINE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER 1 Disclosures

More information

Left Atrial Appendage Closure: The Good, The Bad and The Ugly

Left Atrial Appendage Closure: The Good, The Bad and The Ugly Left Atrial Appendage Closure: The Good, The Bad and The Ugly John D. Hummel, MD Director of Electrophysiology Research Ross Heart Hospital, The Ohio State University Columbus, Ohio USA Disclosures Modest

More information

Congenital Absence of the Left Atrial Appendage Visualized by 3D Echocardiography in Two Adult Patients

Congenital Absence of the Left Atrial Appendage Visualized by 3D Echocardiography in Two Adult Patients DOI: 10.1111/echo.12882 2015, Wiley Periodicals, Inc. Echocardiography CASE REPORT Congenital Absence of the Left Atrial Appendage Visualized by 3D Echocardiography in Two Adult Patients Mona Saleh, B.A.,*

More information

PREVAIL: 5-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure vs Medical Therapy in Patients With Nonvalvular Atrial Fibrillation

PREVAIL: 5-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure vs Medical Therapy in Patients With Nonvalvular Atrial Fibrillation PREVAIL: 5-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure vs Medical Therapy in Patients With Nonvalvular Atrial Fibrillation Dr. Saibal Kar, MD TCT 2017 Late Breaking Clinical

More information

Dad needed to get off his blood thinner. His doctor told us about an alternative. It s called

Dad needed to get off his blood thinner. His doctor told us about an alternative. It s called Dad needed to get off his blood thinner. His doctor told us about an alternative. It s called A one-time procedure that may reduce stroke risk for a lifetime in people with AFib not caused by a heart valve

More information